Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
Journal of Substance Use and Addiction Treatment
|
March 13, 2026
Primary care clinicians' perspectives on an electronic health record-integrated clinical decision support tool for opioid use disorder
Gavin Bart, Caitlin M Borgert-Spaniol, A Lauren Crain, et al.
Neuroimage
|
September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritis
Jaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
Animals : an Open Access Journal From MDPI
|
October 28, 2023
Adult Ossabaw Pigs Prefer Fermented Sorghum Tea over Isocaloric Sweetened Water
Catherine E Nelson, Fadi M Aramouni, Mikayla J Goering, et al.
Journal of the American Pharmacists Association : Japha
|
March 18, 2026
Medication adherence and persistence of newly-initiated medications in older adults with diabetes
Sarah Krahe Dombrowski, Jaejin An, Xuan Huang, et al.
Contemporary Clinical Trials
|
November 19, 2022
Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care
Rebecca C Rossom, A Lauren Crain, Patrick J O'Connor, et al.
Diabetes, Obesity & Metabolism
|
January 2, 2026
Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes
Stephanie A Hooker, Romain S Neugebauer, Julie A Schmittdiel, et al.
Contemporary Clinical Trials
|
January 10, 2026
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics
Caroline Blackwell Young, Emily Rives, Kimberly A Gudzune, et al.
Translational Stroke Research
|
June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion
Peer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Neurobiology of Disease
|
May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates
Peer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
Journal of Substance Use and Addiction Treatment
|
March 13, 2026
Primary care clinicians' perspectives on an electronic health record-integrated clinical decision support tool for opioid use disorder
Gavin Bart, Caitlin M Borgert-Spaniol, A Lauren Crain, et al.
Neuroimage
|
September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritis
Jaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
Animals : an Open Access Journal From MDPI
|
October 28, 2023
Adult Ossabaw Pigs Prefer Fermented Sorghum Tea over Isocaloric Sweetened Water
Catherine E Nelson, Fadi M Aramouni, Mikayla J Goering, et al.
Journal of the American Pharmacists Association : Japha
|
March 18, 2026
Medication adherence and persistence of newly-initiated medications in older adults with diabetes
Sarah Krahe Dombrowski, Jaejin An, Xuan Huang, et al.
Contemporary Clinical Trials
|
November 19, 2022
Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care
Rebecca C Rossom, A Lauren Crain, Patrick J O'Connor, et al.
Diabetes, Obesity & Metabolism
|
January 2, 2026
Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes
Stephanie A Hooker, Romain S Neugebauer, Julie A Schmittdiel, et al.
Contemporary Clinical Trials
|
January 10, 2026
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics
Caroline Blackwell Young, Emily Rives, Kimberly A Gudzune, et al.
Translational Stroke Research
|
June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion
Peer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management
Derek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Neurobiology of Disease
|
May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates
Peer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Page
of 17